Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

Part of paid clinical trials in Sacramento, California.

Sponsor
PSC Partners Seeking a Cure
Study ID
NCT06297993
Status
Recruiting
Apply to this trial

Conditions

  • PSC

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Study Details

Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.

Key Dates

Start date
May 6, 2024
Status verified
Feb 2026
Primary completion
Jan 31, 2029
Completion
Jan 31, 2031

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Adult patients with a confirmed diagnosis of large duct PSC.
    1. Adult patients between 18 and 75 years of age (inclusive) who can comprehend instructions, follow the study procedures and are willing to sign an Informed Consent Form (ICF). 2. Confirmed clinical diagnosis of large duct PSC

Primary Outcome Measure

Develop an appropriate real-world data (RWD) comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC. [ Time Frame: Quarterly for five years from enrollment ]

Central Contacts

Locations (11)

FacilityCityStateZIPSite coordinators
UC DavisSacramentoCalifornia95817
Richard Dean
[email protected]
Christopher Bowlus, MD (PRINCIPAL_INVESTIGATOR)
California Pacific Medical CenterSan FranciscoCalifornia94109
Stefanie Roberts, BS
[email protected]
415-600-1107
Kidist Yimam, MD (PRINCIPAL_INVESTIGATOR)
University of California, San FranciscoSan FranciscoCalifornia94143
Michael Li, MD, MPH (PRINCIPAL_INVESTIGATOR)
Yale UniversityNew HavenConnecticut06510
Suzie Christopher
[email protected]
Marina Silveira, MD (PRINCIPAL_INVESTIGATOR)
Schiff Center for Liver Diseases / University of MiamiMiamiFlorida33136
Cynthia Levy, MD
[email protected]
306.243.4615
Cynthia Levy, MD (PRINCIPAL_INVESTIGATOR)
Indiana UniversityIndianapolisIndiana46202
Rebecca Gerstorff
[email protected]
Craig Lammert, MD (PRINCIPAL_INVESTIGATOR)
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Julie Shea
[email protected]
617-632-1129
Vilas Patwardhan, MD (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Shruti Patel
[email protected]
(516) 508-2213
Daniel Pratt, MD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55901
Paige Powrie
[email protected]
John Eaton, MD (PRINCIPAL_INVESTIGATOR)
UT Southwestern Medical CenterDallasTexas75390
Lakeisha Johnson
[email protected]
214-648-2725
Marlyn Mayo, MD (PRINCIPAL_INVESTIGATOR)
Virginia Commonwealth UniversityRichmondVirginia23298
Caitlin Hurst, BS
[email protected]
(804) 828-9405
Obi Aseem, MD (PRINCIPAL_INVESTIGATOR)
Velimir Luketic, MD (SUB_INVESTIGATOR)
Amon Asgharpour, MD (SUB_INVESTIGATOR)
Shadab Siddiqui, MD (SUB_INVESTIGATOR)

Find similar trials in Sacramento, CA

By research site
UC Davis· Sacramento, CACalifornia Pacific Medical Center· San Francisco, CAUniversity of California, San Francisco· San Francisco, CAYale University· New Haven, CTSchiff Center for Liver Diseases / University of Miami· Miami, FLIndiana University· Indianapolis, IN

Related Studies